Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Are you sure anyone cares?
I still want to know where I sign up to get paid for my apparently highly valued posts, but no one has been able to point me in the right direction nor have any handlers approached me on a recommendation.
I guess the demand for bashing $AVXL is just not anywhere near as high as for pumping. This freelancer business sucks, when there no demand for one’s skills and talent - so sad.
Complete BS!
Another quarter and same story - nothing!
The FDA may not have to concern themselves with EMA approving A2-73 first.
$6000, isn’t that amazing for a military grade analyst.
Also I can't recall a single time where he has been mentioned as achieving anything while at Anavex.
Someone asked this question:
“Since you've been following, how did the various allegations consolidate to the lead plaintiff part?”
I provided help to self help. It’s still a case of waiting until 13th May…
I have done that but some here are just on autopilot 💩 reactions. Head under the arm kinda thing - can’t be helped it seems.
Sounds like you would be disappointed if I am right that the case is likely to be dismissed after May 13th.
Just posting the objective facts to correct an incorrect understanding. You will already know my assessment that the case is likely to be dismissed. We just can’t be sure until after May 13th, similar to the fact that we could not be sure if the Anavex clinical trial outcomes would be a slam dunk success until the readouts demonstrated that they were not.
Chill catdaddy and try learn that knowledge and facts are useful concepts for biotech investors and cat lovers.
You might want to correct that as the court has issued a summons addressed to Christopher Missling, which has been duly executed.
I have provided a link to the case, so you are able to verify,
There is however a good chance the case may be dismissed just after May 13, provided there is no motion for lead plaintiff filed by one or more additional law firms.
Generally motions for lead plaintiff are filed just before the deadline.
So now Missling is being sued!
Maybe more modest aspirations, like say $AVXL once again some day becoming a $8 stock, would be a start of something.
I could see that happen much sooner.
Georgejjl seems to have fetish for finding those that go south.
My guess is that your many and deeply insightful posts here played a big part in attracting another actual Dr. to this message board.
And you don't like AI much as I understand from your posts. So what should we think of this post of yours, that is AI manipulation I guess.
Ma probably paved the way to the groundbreaking Partex partnerships of which will come very little of any benefit unless and until Anavex get a drug to market. To date no regulator has received a marketing authorisation application to look at in its full glory of endless pages upon pages.
it was just BSIG blowing up another load of dry powder. Short lived, but looked good as long as it lasted.
Any figures on people with Asperger's? I am absolutely certain that will be another indication in the pipeline soon. If not with A2-73, then A3-71 or some other Anavex compound.
Exactly! When Missling says Anavex trials and results are blinded, what he really means is that retail investors are being bamboozled into believing readouts are fine even when they are not. Then he keeps promising all sorts of stuff that doesn't happen, while calling it catalysts. After more that 5 years of that many still fall for it.
Let's see Anavex actually filing for approval before worrying about all sorts of at this point immaterial concerns.
What did you have for lunch?
The KEM Formal Concept Analysis is a very specific application of AI mixed with discrete statistics and data analysis.
AI is many things, but the media is not good at explaining the concepts involved and so a lot of people think of AI as magic or even terrifying.
Much more similar than WGT bias allows to contemplate. What was the n of the odds ratios Anavex resorted to report for their P2b/3 readout? Whatever that n was, it represents a subgroup of patients and is an outcome measure that deviates from the expected per protocol outcome measures.
About a furlong.
True of the active drug too. But one difference is that placebo may not affect biomarkers in the same way as the active drug for those given that.
Annovis straight up recognises that a pivotal PIII trial is required!
Anavex or somebody should market the best ever placebo pill, the effect is real and has only imaginary side effects.
It is amazing how the mind can state influence the health of the rest of the body.
It’s a shame the placebo effect can’t be patented, but someone could claim new and effective methods of inducing it.
Were any of the CEOs you advised members of the upper echelons of biotech investors?
Barons doesn’t know more than the rest of us. Based their 12 months $AVXL forecast the MAA filing and validation feels like $40 in their analysis, which would be fine.
Will it happen? We wait to see…
News is always on the way, and
Yes probably more digestible and easy to comprehend a furlong at a time in less than a fortnight.
Probably not, but I would recommend this wonderful rendition of the story:
There is precious little of what you post that is a must see, most is a best ignore!
Missling opened up for the possibility that the P2b/3 full data presentation could happen prior to and independent of a published peer reviewed article. One interpretation of that could be that a journal is taking an indefinite time process the peer review and publishing, or it has been declined. Another could be that the data presentation is coinciding with something yet to be revealed e.g. MAA submission, a scientific conference or any other wonderfulness.
Yes wait until just after 13th May that little problem might not consume to whole ASM.
85% chance.
Nope we write the script, always steps ahead you!